HCQ use unlikely to prevent Covid infection: Study

The randomised double-blind placebo trial was to study the efficacy of the controversial but commonly used drug in post-exposure prophylaxis — or as a preventive measure in high-risk contacts such as those who were living with a Covid-19 positive patient.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dvqWCi
via IFTTT